Synergistic antidepressant-like action of gaboxadol and escitalopram

European Neuropsychopharmacology

Volumn 22, Issue 10, 2012, Pages 751-760

  Christensen, Trine ^a   Bétry, Cécile ^b   Mnie Filali, Ouissame ^b   Etievant, Adeline ^b   Ebert, Bjarke ^c   Haddjeri, Nasser ^b   Wiborg, Ove ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITÉ LYON 1   (France)

^c H LUNDBECK A S   (Denmark)

Author keywords

Adult neurogenesis; Antidepressants; Chronic mild stress; Depression; Serotonergic firing rates

Indexed keywords

ESCITALOPRAM; GABOXADOL; NEURON SPECIFIC NUCLEAR PROTEIN; SUCROSE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CELL PROLIFERATION; CHRONIC STRESS; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DORSAL RAPHE NUCLEUS; DRUG ANTAGONISM; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; EXPERIMENTAL MODEL; IMMUNOHISTOCHEMISTRY; MALE; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CITALOPRAM; DENTATE GYRUS; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GABA-A RECEPTOR AGONISTS; ISOXAZOLES; MALE; NEUROGENESIS; NEURONS; RAPHE NUCLEI; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 84865551889     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.02.001     Document Type: Article

References (52)

1. Aghajanian G.K. Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. Essays Neurochem. Neuropharmacol. 1978, 3:1-32.
2. Bagdy E., Kiraly I., Harsing L.G. Reciprocal innervation between serotonergic and GABAergic neurons in raphe nuclei of the rat. Neurochem. Res. 2000, 25:1465-1473.
3. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
4. Belelli D., Peden D.R., Rosahl T.W., Wafford K.A., Lambert J.J. Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics. J. Neurosci. 2005, 25:11513-11520.
5. Bessa J.M., Ferreira D., Melo I., Marques F., Cerqueira J.J., Palha J.A., et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol. Psychiatry 2009, 14(764-73):739.
6. Blier P., De Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 1999, 21:91S-98S.
7. Brambilla P., Perez J., Barale F., Schettini G., Soares J.C. GABAergic dysfunction in mood disorders. Mol. Psychiatry 2003, 8(721-37):715.
8. Brown R.E., Sergeeva O.A., Eriksson K.S., Haas H.L. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J. Neurosci. 2002, 22:8850-8859.
9. Cameron H.A., McKay R.D. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J. Comp. Neurol. 2001, 435:406-417.
10. Celada P., Puig M.V., Casanovas J.M., Guillazo G., Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. J. Neurosci. 2001, 21:9917-9929.
11. Croarkin P.E., Levinson A.J., Daskalakis Z.J. Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci. Biobehav. Rev. 2011, 35:818-825.
12. Czachura J.F., Rasmussen K. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn-Schmiedebergs Arch. Pharmacol. 2000, 362:266-275.
13. Devanand D.P., Lisanby S., Lo E.S., Fitzsimons L., Cooper T.B., Halbreich U., et al. Effects of electroconvulsive therapy on plasma vasopressin and oxytocin. Biol. Psychiatry 1998, 44:610-616.
14. Dorostkar M.M., Boehm S. Opposite effects of presynaptic 5-HT3 receptor activation on spontaneous and action potential-evoked GABA release at hippocampal synapses. J. Neurochem. 2007, 100:395-405.
15. El Mansari M., Sanchez C., Chouvet G., Renaud B., Haddjeri N. Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 2005, 30:1269-1277.
16. Farrant M., Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat. Rev. Neurosci. 2005, 6:215-229.
17. Faure C., Mnie-Filali O., Haddjeri N. Long-term adaptive changes induced by serotonergic antidepressant drugs. Expert. Rev. Neurother. 2006, 6:235-245.
18. Ford D.E., Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. JAMA 1989, 262:1479-1484.
19. Ge S., Pradhan D.A., Ming G.L., Song H. GABA sets the tempo for activity-dependent adult neurogenesis. Trends Neurosci. 2007, 30:1-8.
20. Gronli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Ursin R., et al. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behav. Brain Res. 2007, 181:42-51.
21. Haddjeri N., Blier P. Pre- and post-synaptic effects of the 5-HT3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain. Synapse 1995, 20:54-67.
22. Hajos M., Hajos-Korcsok E., Sharp T. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br. J. Pharmacol. 1999, 126:1741-1750.
23. Hanson N.D., Owens M.J., Nemeroff C.B. Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 2011, 36:2589-2602.
24. Harsing L.G. The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat. Curr. Neuropharmacol. 2006, 4:313-339.
25. Henningsen K., Andreasen J.T., Bouzinova E.V., Jayatissa M.N., Jensen M.S., Redrobe J.P., et al. Cognitive deficits in the rat chronic mild stress model for depression: relation to anhedonic-like responses. Behav. Brain Res. 2009, 198:136-141.
26. Holm M.M., Nieto-Gonzalez J.L., Vardya I., Henningsen K., Jayatissa M.N., Wiborg O., Jensen K. Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression. Hippocampus 2011, 21:422-433.
27. Jacobs B.L., Fornal C.A. Activity of brain serotonergic neurons in the behaving animal. Pharmacol. Rev. 1991, 43:563-578.
28. Jayatissa M.N., Bisgaard C., Tingström A., Papp M., Wiborg O. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 2006, 31:2395-2404.
29. Jayatissa M.N., Bisgaard C.F., West M.J., Wiborg O. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology 2008, 54:530-541.
30. Jayatissa M.N., Henningsen K., West M.J., Wiborg O. Decreased cell proliferation in the dentate gyrus does not associate with development of anhedonic-like symptoms in rats. Brain Res. 2009, 1290:133-141.
31. Jayatissa M.N., Henningsen K., Nikolajsen G., West M.J., Wiborg O. A reduced number of hippocampal granule cells does not associate with an anhedonia-like phenotype in a rat chronic mild stress model of depression. Stress 2010, 13:95-105.
32. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
33. Krogsgaard-Larsen P., Frølund B., Liljefors T. GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. Adv. Pharmacol. 2006, 54:53-71.
34. Levinson A.J., Fitzgerald P.B., Favalli G., Blumberger D.M., Daigle M., Daskalakis Z.J. Evidence of cortical inhibitory deficits in major depressive disorder. Biol. Psychiatry 2010, 67:458-464.
35. Luparini M.R., Garrone B., Pazzagli M., Pinza M., Pepeu G. A cortical GABA-5HT interaction in the mechanism of action of the antidepressant trazodone. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:1117-1127.
36. Luscher B., Shen Q., Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol. Psychiatry 2011, 16:383-406.
37. Luttgen M., Ove O.S., Meister B. Chemical identity of 5-HT2A receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus. Brain Res. 2004, 1010:156-165.
38. Morales M., Bloom F.E. The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J. Neurosci. 1997, 17:3157-3167.
39. Park J.B., Skalska S., Son S., Stern J.E. Dual GABAA receptor-mediated inhibition in rat presympathetic paraventricular nucleus neurons. J. Physiol. 2007, 582:539-551.
40. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, New York.
41. Perera T.D., Park S., Nemirovskaya Y. Cognitive role of neurogenesis in depression and antidepressant treatment. Neuroscientist 2008, 14:326-338.
42. Pineyro G., Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 1999, 51:533-591.
43. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000, 101:815-850.
44. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 1965, 122:509-522.
45. Song C., Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neurosci. Biobehav. Rev. 2005, 29:627-647.
46. Storustovu S.I., Ebert B. Pharmacological characterization of agonists at delta-containing GABAA receptors: functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2. J. Pharmacol. Exp. Ther. 2006, 316:1351-1359.
47. Thase M.E. Antidepressant treatment of the depressed patient with insomnia. J. Clin. Psychiatry 1999, 60(Suppl 17):28-31.
48. Tozuka Y., Fukuda S., Namba T., Seki T., Hisatsune T. GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells. Neuron 2005, 47:803-815.
49. Turner T.J., Mokler D.J., Luebke J.I. Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies. Neuroscience 2004, 129:703-718.
50. Wang D.D., Kriegstein A.R. Defining the role of GABA in cortical development. J. Physiol. 2009, 587:1873-1879.
51. Warner-Schmidt J.L., Duman R.S. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006, 16:239-249.
52. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.